Further analysis confirmed that CRP and the CAR are the optimal biomarkers for diagnosing PJI in diabetic patients, and the diagnostic value of both is not affected by the site of joint involvement or the results of pathogenic bacteria culture. Here, CRP is linked to juvenile polyposis syndrome.